Page 65 - Read Online

Ciolino et al. J Transl Genet Genom 2022;6:429-42 https://dx.doi.org/10.20517/jtgg.2022.15 Page 441

6. Zurita MF, Cárdenas PA, Sandoval ME, et al. Analysis of gut microbiome, nutrition and immune status in autism spectrum disorder: a
case-control study in Ecuador. Gut Microbes 2020;11:453-64. DOI PubMed PMC
7. Myers SM, Challman TD, Bernier R, et al. Insufficient evidence for “autism-specific” genes. Am J Hum Genet 2020;106:587-95. DOI
PubMed PMC
8. Lisik MZ, Gutmajster E, Sieroń AL. Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in
its pathogenesis? Neurodegener Dis 2015;15:45-9. DOI PubMed
9. Marco BD, Bonaccorso CM, Aloisi E, D'Antoni S, Catania MV. Neuro-inflammatory mechanisms in developmental disorders
associated with intellectual disability and autism spectrum disorder: a neuro- immune perspective. CNS Neurol Disord Drug Targets
2016;15:448-63. DOI PubMed
10. Barnhill K, Devlin M, Moreno HT, et al. Brief report: implementation of a specific carbohydrate diet for a child with autism spectrum
disorder and fragile X syndrome. J Autism Dev Disord 2020;50:1800-8. DOI PubMed
11. Nolan SO, Hodges SL, Binder MS, et al. Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse. PLoS One
2022;17:e0262916. DOI PubMed PMC
12. Napoli E, Schneider A, Wang JY, et al. Allopregnanolone treatment improves plasma metabolomic profile associated with gaba
metabolism in fragile X-associated tremor/ataxia syndrome: a pilot study. Mol Neurobiol 2019;56:3702-13. DOI PubMed PMC
13. Song G, Napoli E, Wong S, et al. Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia
syndrome: use of antioxidants in precision medicine. Mol Med 2016;22:548-59. DOI PubMed PMC
14. Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual
disability-related diseases: an overview of Down syndrome, Autism, Fragile X and Rett syndrome. Neurosci Biobehav Rev 2014;46 Pt
2:202-17. DOI PubMed
15. Müller M. Disturbed redox homeostasis and oxidative stress: potential players in the developmental regression in Rett syndrome.
Neurosci Biobehav Rev 2019;98:154-63. DOI PubMed
16. Carlsson T, Rosenqvist M, Butwicka A, et al. Association of cumulative early medical factors with autism and autistic symptoms in a
population-based twin sample. Transl Psychiatry 2022;12:73. DOI PubMed PMC
17. Torres EB. Reframing psychiatry for precision medicine. J Pers Med 2020;10:144. DOI PubMed PMC
18. Volk HE, Ames JL, Chen A, et al. Considering toxic chemicals in the etiology of autism. Pediatrics 2022;149:e2021053012. DOI
PubMed
19. Bougeard C, Picarel-Blanchot F, Schmid R, Campbell R, Buitelaar J. Prevalence of autism spectrum disorder and co-morbidities in
children and adolescents: a systematic literature review. Front Psychiatry 2021;12:744709. DOI PubMed PMC
20. Leader G, Abberton C, Cunningham S, et al. Gastrointestinal symptoms in autism spectrum disorder: a systematic review. Nutrients
2022;14:1471. DOI
21. Isaksson J, Ruchkin V, Aho N, Lundin Remnélius K, Marschik PB, Bölte S. Nonshared environmental factors in the aetiology of
autism and other neurodevelopmental conditions: a monozygotic co-twin control study. Mol Autism 2022;13:8. DOI PubMed PMC
22. Wei H, Zhu Y, Wang T, Zhang X, Zhang K, Zhang Z. Genetic risk factors for autism-spectrum disorders: a systematic review based on
systematic reviews and meta-analysis. J Neural Transm 2021;128:717-34. DOI PubMed
23. David MM, Enard D, Ozturk A, et al. Comorbid analysis of genes associated with autism spectrum disorders reveals differential
evolutionary constraints. PLoS One 2016;11:e0157937. DOI
24. Diaz-Beltran L, Esteban FJ, Varma M, et al. Cross-disorder comparative analysis of comorbid conditions reveals novel autism
candidate genes. BMC Genomics 2017;18:1-14. DOI
25. Klein L, D'Urso S, Eapen V, Hwang LD, Lin PI. Exploring polygenic contributors to subgroups of comorbid conditions in autism
spectrum disorder. Sci Rep 2022;12:3416. DOI PubMed PMC
26. Ferreira ML, Loyacono N. Rationale of an advanced integrative approach applied to autism spectrum disorder: review, discussion and
proposal. J Pers Med 2021;11:514. DOI PubMed PMC
27. Cawthorpe D. A 16-year cohort analysis of autism spectrum disorder-associated morbidity in a pediatric population. Front Psychiatry
2018;9:635. DOI PubMed PMC
28. Ozonoff S, Gangi D, Hanzel EP, et al. Onset patterns in autism: variation across informants, methods, and timing. Autism Res
2018;11:788-97. DOI PubMed PMC
29. Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE. Clinical and molecular characteristics of mitochondrial
dysfunction in autism spectrum disorder. Mol Diagn Ther 2018;22:571-93. DOI PubMed PMC
30. Goncalves MVM, Harger R, Braatz V, et al. Pediatric acute-onset neuropsychiatric syndrome (PANS) misdiagnosed as autism
spectrum disorder. Immunol Lett 2018;203:52-3. DOI PubMed
31. Shulyakova N, Andreazza AC, Mills LR, Eubanks JH. Mitochondrial dysfunction in the pathogenesis of rett syndrome: implications
for mitochondria-targeted therapies. Front Cell Neurosci 2017;11:58. DOI PubMed PMC
32. Kreiman BL, Boles RG. State of the art of genetic testing for patients with autism: a practical guide for clinicians. Semin Pediatr
Neurol 2020;34:100804. DOI PubMed
33. Stafford CF, Sanchez-Lara PA. Impact of genetic and genomic testing on the clinical management of patients with autism spectrum
disorder. Genes 2022;13:585. DOI PubMed PMC
34. Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a
systematic review and meta-analysis. Lancet Psychiatry 2015;2:909-16. DOI PubMed